APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Injectable Drug Delivery Formulation

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Injectable Drug Delivery Formulation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174003070322 December 2025186 pages

Choose your research edition.

Industry ResearchInjectable Drug Delivery Formulation Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Injectable Drug Delivery Formulation Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Injectable Drug Delivery Formulation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Injectable Drug Delivery Formulation Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Injectable Drug Delivery Formulation Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Injectable Drug Delivery Formulation market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Injectable Drug Delivery Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Injectable Drug Delivery Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Injectable Drug Delivery Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Injectable Drug Delivery Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Injectable Drug Delivery Formulation include Teva Pharmaceutical Industries Ltd. (Israel), Sandoz (Germany), Eli Lilly and Company (US), Pfizer, Inc. (US), Baxter International Inc. (US), Schott AG (Germany), Gerresheimer AG (Germany) and Becton, Dickinson and Company (US), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Injectable Drug Delivery Formulation market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Injectable Drug Delivery Formulation and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Injectable Drug Delivery Formulation sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Injectable Drug Delivery Formulation market size, projected growth trends, production technologies, key applications, and end-use industries.

Injectable Drug Delivery Formulation Segment by Company

Teva Pharmaceutical Industries Ltd. (Israel)

Sandoz (Germany)

Eli Lilly and Company (US)

Pfizer, Inc. (US)

Baxter International Inc. (US)

Schott AG (Germany)

Gerresheimer AG (Germany)

Becton, Dickinson and Company (US)

Injectable Drug Delivery Formulation Segment by Type

Conventional Drug Delivery Formulations

Novel Drug Delivery Formulations

Long-acting Formulations

Injectable Drug Delivery Formulation Segment by Application

Orphan Diseases

Hormonal Disorders

Oncology

Autoimmune Diseases

Others

Injectable Drug Delivery Formulation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Drug Delivery Formulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Injectable Drug Delivery Formulation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Drug Delivery Formulation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Injectable Drug Delivery Formulation market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Injectable Drug Delivery Formulation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Injectable Drug Delivery Formulation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Injectable Drug Delivery Formulation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Injectable Drug Delivery Formulation Industry Trends Table 2. Injectable Drug Delivery Formulation Industry Drivers Table 3. Injectable Drug Delivery Formulation Industry Opportunities and Challenges Table 4. Injectable Drug Delivery Formulation Industry Restraints Table 5. Global Injectable Drug Delivery Formulation Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Injectable Drug Delivery Formulation Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Injectable Drug Delivery Formulation Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Injectable Drug Delivery Formulation Sales Market Share by Manufacturers Table 9. Global Injectable Drug Delivery Formulation Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Injectable Drug Delivery Formulation Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Injectable Drug Delivery Formulation Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Injectable Drug Delivery Formulation Manufacturers, Product Type & Application Table 13. Global Injectable Drug Delivery Formulation Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Injectable Drug Delivery Formulation by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Conventional Drug Delivery Formulations Table 17. Major Manufacturers of Novel Drug Delivery Formulations Table 18. Major Manufacturers of Long-acting Formulations Table 19. Global Injectable Drug Delivery Formulation Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Injectable Drug Delivery Formulation Sales by Type (2021-2026) & (k units) Table 21. Global Injectable Drug Delivery Formulation Sales by Type (2027-2032) & (k units) Table 22. Global Injectable Drug Delivery Formulation Sales Market Share by Type (2021-2026) Table 23. Global Injectable Drug Delivery Formulation Sales Market Share by Type (2027-2032) Table 24. Global Injectable Drug Delivery Formulation Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Injectable Drug Delivery Formulation Revenue by Type (2021-2026) & (k units) Table 26. Global Injectable Drug Delivery Formulation Revenue by Type (2027-2032) & (k units) Table 27. Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2021-2026) Table 28. Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Orphan Diseases Table 30. Major Manufacturers of Hormonal Disorders Table 31. Major Manufacturers of Oncology Table 32. Major Manufacturers of Autoimmune Diseases Table 33. Major Manufacturers of Others Table 34. Global Injectable Drug Delivery Formulation Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Injectable Drug Delivery Formulation Sales by Application (2021-2026) & (k units) Table 36. Global Injectable Drug Delivery Formulation Sales by Application (2027-2032) & (k units) Table 37. Global Injectable Drug Delivery Formulation Sales Market Share by Application (2021-2026) Table 38. Global Injectable Drug Delivery Formulation Sales Market Share by Application (2027-2032) Table 39. Global Injectable Drug Delivery Formulation Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Injectable Drug Delivery Formulation Revenue by Application (2021-2026) & (k units) Table 41. Global Injectable Drug Delivery Formulation Revenue by Application (2027-2032) & (k units) Table 42. Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2021-2026) Table 43. Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2027-2032) Table 44. Global Injectable Drug Delivery Formulation Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Injectable Drug Delivery Formulation Sales by Region (2021-2026) & (k units) Table 46. Global Injectable Drug Delivery Formulation Sales Market Share by Region (2021-2026) Table 47. Global Injectable Drug Delivery Formulation Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Injectable Drug Delivery Formulation Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Injectable Drug Delivery Formulation Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Injectable Drug Delivery Formulation Sales by Country (2021-2026) & (k units) Table 51. North America Injectable Drug Delivery Formulation Sales by Country (2027-2032) & (k units) Table 52. Europe Injectable Drug Delivery Formulation Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Injectable Drug Delivery Formulation Sales by Country (2021-2026) & (k units) Table 54. Europe Injectable Drug Delivery Formulation Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Injectable Drug Delivery Formulation Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Injectable Drug Delivery Formulation Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Injectable Drug Delivery Formulation Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Injectable Drug Delivery Formulation Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2027-2032) & (k units) Table 61. Global Injectable Drug Delivery Formulation Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Injectable Drug Delivery Formulation Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Injectable Drug Delivery Formulation Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Injectable Drug Delivery Formulation Revenue Market Share by Region (2021-2026) Table 65. Global Injectable Drug Delivery Formulation Revenue Market Share by Region (2027-2032) Table 66. Teva Pharmaceutical Industries Ltd. (Israel) Company Information Table 67. Teva Pharmaceutical Industries Ltd. (Israel) Business Overview Table 68. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product Portfolio Table 70. Teva Pharmaceutical Industries Ltd. (Israel) Recent Development Table 71. Sandoz (Germany) Company Information Table 72. Sandoz (Germany) Business Overview Table 73. Sandoz (Germany) Injectable Drug Delivery Formulation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Sandoz (Germany) Injectable Drug Delivery Formulation Product Portfolio Table 75. Sandoz (Germany) Recent Development Table 76. Eli Lilly and Company (US) Company Information Table 77. Eli Lilly and Company (US) Business Overview Table 78. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product Portfolio Table 80. Eli Lilly and Company (US) Recent Development Table 81. Pfizer, Inc. (US) Company Information Table 82. Pfizer, Inc. (US) Business Overview Table 83. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product Portfolio Table 85. Pfizer, Inc. (US) Recent Development Table 86. Baxter International Inc. (US) Company Information Table 87. Baxter International Inc. (US) Business Overview Table 88. Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Baxter International Inc. (US) Injectable Drug Delivery Formulation Product Portfolio Table 90. Baxter International Inc. (US) Recent Development Table 91. Schott AG (Germany) Company Information Table 92. Schott AG (Germany) Business Overview Table 93. Schott AG (Germany) Injectable Drug Delivery Formulation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Schott AG (Germany) Injectable Drug Delivery Formulation Product Portfolio Table 95. Schott AG (Germany) Recent Development Table 96. Gerresheimer AG (Germany) Company Information Table 97. Gerresheimer AG (Germany) Business Overview Table 98. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product Portfolio Table 100. Gerresheimer AG (Germany) Recent Development Table 101. Becton, Dickinson and Company (US) Company Information Table 102. Becton, Dickinson and Company (US) Business Overview Table 103. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product Portfolio Table 105. Becton, Dickinson and Company (US) Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Injectable Drug Delivery Formulation Distributors List Table 109. Injectable Drug Delivery Formulation Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Injectable Drug Delivery Formulation Product Image Figure 2. Global Injectable Drug Delivery Formulation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Injectable Drug Delivery Formulation Market Size (2021-2032) & (US$ Million) Figure 4. Global Injectable Drug Delivery Formulation Sales (2021-2032) & (k units) Figure 5. Global Injectable Drug Delivery Formulation Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Injectable Drug Delivery Formulation Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Conventional Drug Delivery Formulations Image Figure 9. Novel Drug Delivery Formulations Image Figure 10. Long-acting Formulations Image Figure 11. Global Injectable Drug Delivery Formulation Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Injectable Drug Delivery Formulation Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Injectable Drug Delivery Formulation Sales Market Share by Type (2021-2032) Figure 14. Global Injectable Drug Delivery Formulation Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Injectable Drug Delivery Formulation Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2021-2032) Figure 17. Orphan Diseases Image Figure 18. Hormonal Disorders Image Figure 19. Oncology Image Figure 20. Autoimmune Diseases Image Figure 21. Others Image Figure 22. Global Injectable Drug Delivery Formulation Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Injectable Drug Delivery Formulation Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Injectable Drug Delivery Formulation Sales Market Share by Application (2021-2032) Figure 25. Global Injectable Drug Delivery Formulation Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Injectable Drug Delivery Formulation Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2021-2032) Figure 28. North America Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Injectable Drug Delivery Formulation Sales Market Share by Country (2021-2032) Figure 30. U.S. Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Injectable Drug Delivery Formulation Sales Market Share by Country (2021-2032) Figure 35. Germany Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Injectable Drug Delivery Formulation Sales Market Share by Country (2021-2032) Figure 42. China Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share by Country (2021-2032) Figure 50. Brazil Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Injectable Drug Delivery Formulation Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Injectable Drug Delivery Formulation Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Injectable Drug Delivery Formulation Revenue (2021-2032) & (US$ Million) Figure 61. North America Injectable Drug Delivery Formulation Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Injectable Drug Delivery Formulation Revenue (2021-2032) & (US$ Million) Figure 63. Europe Injectable Drug Delivery Formulation Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Injectable Drug Delivery Formulation Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Injectable Drug Delivery Formulation Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Injectable Drug Delivery Formulation Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Injectable Drug Delivery Formulation Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Injectable Drug Delivery Formulation Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Injectable Drug Delivery Formulation Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Conventional Drug Delivery Formulations
  • Novel Drug Delivery Formulations
  • Long-acting Formulations
Applications
  • Orphan Diseases
  • Hormonal Disorders
  • Oncology
  • Autoimmune Diseases
  • Others
Companies covered
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Sandoz (Germany)
  • Eli Lilly and Company (US)
  • Pfizer, Inc. (US)
  • Baxter International Inc. (US)
  • Schott AG (Germany)
  • Gerresheimer AG (Germany)
  • Becton, Dickinson and Company (US)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Injectable Drug Delivery Formulation Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Injectable Drug Delivery Formulation Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Injectable Drug Delivery Formulation Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Injectable Drug Delivery Formulation Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Injectable Drug Delivery Formulation Market Dynamics
  1. 2.1 Injectable Drug Delivery Formulation Industry Trends
  2. 2.2 Injectable Drug Delivery Formulation Industry Drivers
  3. 2.3 Injectable Drug Delivery Formulation Industry Opportunities and Challenges
  4. 2.4 Injectable Drug Delivery Formulation Industry Restraints
3 Injectable Drug Delivery Formulation Market by Manufacturers
  1. 3.1 Global Injectable Drug Delivery Formulation Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Injectable Drug Delivery Formulation Sales by Manufacturers (2021-2026)
  3. 3.3 Global Injectable Drug Delivery Formulation Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Injectable Drug Delivery Formulation Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Injectable Drug Delivery Formulation Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Injectable Drug Delivery Formulation Manufacturers, Product Type & Application
  7. 3.7 Global Injectable Drug Delivery Formulation Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Injectable Drug Delivery Formulation Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Injectable Drug Delivery Formulation Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Injectable Drug Delivery Formulation Tier 1, Tier 2, and Tier 3
4 Injectable Drug Delivery Formulation Market by Type
  1. 4.1 Injectable Drug Delivery Formulation Type Introduction
  2. 4.1.1 Conventional Drug Delivery Formulations
  3. 4.1.2 Novel Drug Delivery Formulations
  4. 4.1.3 Long-acting Formulations
  5. 4.2 Global Injectable Drug Delivery Formulation Sales by Type
  6. 4.2.1 Global Injectable Drug Delivery Formulation Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Injectable Drug Delivery Formulation Sales by Type (2021-2032)
  8. 4.2.3 Global Injectable Drug Delivery Formulation Sales Market Share by Type (2021-2032)
  9. 4.3 Global Injectable Drug Delivery Formulation Revenue by Type
  10. 4.3.1 Global Injectable Drug Delivery Formulation Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Injectable Drug Delivery Formulation Revenue by Type (2021-2032)
  12. 4.3.3 Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2021-2032)
5 Injectable Drug Delivery Formulation Market by Application
  1. 5.1 Injectable Drug Delivery Formulation Application Introduction
  2. 5.1.1 Orphan Diseases
  3. 5.1.2 Hormonal Disorders
  4. 5.1.3 Oncology
  5. 5.1.4 Autoimmune Diseases
  6. 5.1.5 Others
  7. 5.2 Global Injectable Drug Delivery Formulation Sales by Application
  8. 5.2.1 Global Injectable Drug Delivery Formulation Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Injectable Drug Delivery Formulation Sales by Application (2021-2032)
  10. 5.2.3 Global Injectable Drug Delivery Formulation Sales Market Share by Application (2021-2032)
  11. 5.3 Global Injectable Drug Delivery Formulation Revenue by Application
  12. 5.3.1 Global Injectable Drug Delivery Formulation Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Injectable Drug Delivery Formulation Revenue by Application (2021-2032)
  14. 5.3.3 Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2021-2032)
6 Global Injectable Drug Delivery Formulation Sales by Region
  1. 6.1 Global Injectable Drug Delivery Formulation Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Injectable Drug Delivery Formulation Sales by Region (2021-2032)
  3. 6.2.1 Global Injectable Drug Delivery Formulation Sales by Region (2021-2026)
  4. 6.2.2 Global Injectable Drug Delivery Formulation Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Injectable Drug Delivery Formulation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Injectable Drug Delivery Formulation Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Injectable Drug Delivery Formulation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Injectable Drug Delivery Formulation Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Injectable Drug Delivery Formulation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Injectable Drug Delivery Formulation Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Injectable Drug Delivery Formulation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Injectable Drug Delivery Formulation Revenue by Region
  1. 7.1 Global Injectable Drug Delivery Formulation Revenue by Region
  2. 7.1.1 Global Injectable Drug Delivery Formulation Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Injectable Drug Delivery Formulation Revenue by Region (2021-2026)
  4. 7.1.3 Global Injectable Drug Delivery Formulation Revenue by Region (2027-2032)
  5. 7.1.4 Global Injectable Drug Delivery Formulation Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Injectable Drug Delivery Formulation Revenue (2021-2032)
  8. 7.2.2 North America Injectable Drug Delivery Formulation Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Injectable Drug Delivery Formulation Revenue (2021-2032)
  11. 7.3.2 Europe Injectable Drug Delivery Formulation Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Injectable Drug Delivery Formulation Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Injectable Drug Delivery Formulation Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Injectable Drug Delivery Formulation Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Injectable Drug Delivery Formulation Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries Ltd. (Israel)
  2. 8.1.1 Teva Pharmaceutical Industries Ltd. (Israel) Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Ltd. (Israel) Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Ltd. (Israel) Recent Developments
  7. 8.2 Sandoz (Germany)
  8. 8.2.1 Sandoz (Germany) Company Information
  9. 8.2.2 Sandoz (Germany) Business Overview
  10. 8.2.3 Sandoz (Germany) Injectable Drug Delivery Formulation Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sandoz (Germany) Injectable Drug Delivery Formulation Product Portfolio
  12. 8.2.5 Sandoz (Germany) Recent Developments
  13. 8.3 Eli Lilly and Company (US)
  14. 8.3.1 Eli Lilly and Company (US) Company Information
  15. 8.3.2 Eli Lilly and Company (US) Business Overview
  16. 8.3.3 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product Portfolio
  18. 8.3.5 Eli Lilly and Company (US) Recent Developments
  19. 8.4 Pfizer, Inc. (US)
  20. 8.4.1 Pfizer, Inc. (US) Company Information
  21. 8.4.2 Pfizer, Inc. (US) Business Overview
  22. 8.4.3 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product Portfolio
  24. 8.4.5 Pfizer, Inc. (US) Recent Developments
  25. 8.5 Baxter International Inc. (US)
  26. 8.5.1 Baxter International Inc. (US) Company Information
  27. 8.5.2 Baxter International Inc. (US) Business Overview
  28. 8.5.3 Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Baxter International Inc. (US) Injectable Drug Delivery Formulation Product Portfolio
  30. 8.5.5 Baxter International Inc. (US) Recent Developments
  31. 8.6 Schott AG (Germany)
  32. 8.6.1 Schott AG (Germany) Company Information
  33. 8.6.2 Schott AG (Germany) Business Overview
  34. 8.6.3 Schott AG (Germany) Injectable Drug Delivery Formulation Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Schott AG (Germany) Injectable Drug Delivery Formulation Product Portfolio
  36. 8.6.5 Schott AG (Germany) Recent Developments
  37. 8.7 Gerresheimer AG (Germany)
  38. 8.7.1 Gerresheimer AG (Germany) Company Information
  39. 8.7.2 Gerresheimer AG (Germany) Business Overview
  40. 8.7.3 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product Portfolio
  42. 8.7.5 Gerresheimer AG (Germany) Recent Developments
  43. 8.8 Becton, Dickinson and Company (US)
  44. 8.8.1 Becton, Dickinson and Company (US) Company Information
  45. 8.8.2 Becton, Dickinson and Company (US) Business Overview
  46. 8.8.3 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product Portfolio
  48. 8.8.5 Becton, Dickinson and Company (US) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Injectable Drug Delivery Formulation Value Chain Analysis
  2. 9.1.1 Injectable Drug Delivery Formulation Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Injectable Drug Delivery Formulation Production Mode & Process
  6. 9.2 Injectable Drug Delivery Formulation Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Injectable Drug Delivery Formulation Distributors
  9. 9.2.3 Injectable Drug Delivery Formulation Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst